tert-Butyl (3-amino-3-oxopropyl)carbamate, 97%, 25g

(3-Cyanopyridin-4-yl)boronic acid, 95+%, 5g

Methyl 4-iodo-2-methoxybenzoate, 97%, 25g

5-Fluoro-nicotinic acid tert-butyl ester, 95.0%, 1g

n-(3-Bromophenyl)benzenesulfonamide, 95%, 250mg

N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide, 5mg

2-(3-Chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

8-Hydroxyquinoline-5-sulfonic acid hydrate, 95.0%, 5g

Methyl 1-(2-(benzyloxy)ethyl)cyclohexanecarboxylate, 100mg

5-Methyl-2,3-dihydro-1H-inden-1-ol, 95.0%, 5g

E-plan EPLi 20x/0.40 infinitely corrected IOS objective. Working distance 2.61 mm

Ruthenium(III) iodide, anhydrous, 97%, 10g

Methyl 2-bromovalerate, 97.0%, 25g